Mantle Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.
作者信息
Alzahrani Musa, Sagheir Ahmed, Motabi Ibraheem, Dada Reyad, Al-Mansour Mubarak, Alhashmi Hani, Kandil Magdy, Alhejazi Ayman
机构信息
Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Oncology Institute, John Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.
出版信息
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):226-230. doi: 10.4103/sjmms.sjmms_105_19. Epub 2019 Aug 28.
Abstract
摘要
相似文献
1
Mantle Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.套细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):226-230. doi: 10.4103/sjmms.sjmms_105_19. Epub 2019 Aug 28.
2
Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.沙特淋巴瘤小组关于2019冠状病毒病大流行期间各类淋巴瘤患者诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2020 Sep-Dec;8(3):227-238. doi: 10.4103/sjmms.sjmms_457_20. Epub 2020 Aug 20.
3
Diffuse Large B-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.弥漫性大B细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):209-213. doi: 10.4103/sjmms.sjmms_98_19. Epub 2019 Aug 28.
4
Natural Killer/T-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.自然杀伤细胞/ T细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理和随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):222-225. doi: 10.4103/sjmms.sjmms_104_19. Epub 2019 Aug 28.
5
Primary Mediastinal Large B-Cell Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.原发性纵隔大B细胞淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):231-233. doi: 10.4103/sjmms.sjmms_106_19. Epub 2019 Aug 28.
6
Follicular Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.滤泡性淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):214-218. doi: 10.4103/sjmms.sjmms_101_19. Epub 2019 Aug 28.
7
Hodgkin's Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.霍奇金淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):195-201. doi: 10.4103/sjmms.sjmms_96_19. Epub 2019 Aug 28.
8
Marginal Zone Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.边缘区淋巴瘤：沙特淋巴瘤组诊断、管理及随访临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):202-208. doi: 10.4103/sjmms.sjmms_97_19. Epub 2019 Aug 28.
9
Primary Central Nervous System Lymphoma: Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up.原发性中枢神经系统淋巴瘤：沙特淋巴瘤小组关于诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2019 Sep-Dec;7(3):219-221. doi: 10.4103/sjmms.sjmms_103_19. Epub 2019 Aug 28.
10
Gamma distribution model of diffusion MRI for the differentiation of primary central nerve system lymphomas and glioblastomas.扩散 MRI 的伽马分布模型在原发性中枢神经系统淋巴瘤和胶质母细胞瘤鉴别中的应用。
PLoS One. 2020 Dec 14;15(12):e0243839. doi: 10.1371/journal.pone.0243839. eCollection 2020.
引用本文的文献
1
Saudi Lymphoma Group's Clinical Practice Guidelines for Diagnosis, Management and Follow-up of Patients with Various Types of Lymphoma during the Coronavirus Disease 2019 Pandemic.沙特淋巴瘤小组关于2019冠状病毒病大流行期间各类淋巴瘤患者诊断、管理及随访的临床实践指南
Saudi J Med Med Sci. 2020 Sep-Dec;8(3):227-238. doi: 10.4103/sjmms.sjmms_457_20. Epub 2020 Aug 20.
本文引用的文献
1
Ibrutinib, lenalidomide, and rituximab in relapsed or refractory mantle cell lymphoma (PHILEMON): a multicentre, open-label, single-arm, phase 2 trial.伊布替尼、来那度胺和利妥昔单抗治疗复发或难治性套细胞淋巴瘤（PHILEMON）：一项多中心、开放标签、单臂、2期试验。
Lancet Haematol. 2018 Mar;5(3):e109-e116. doi: 10.1016/S2352-3026(18)30018-8. Epub 2018 Jan 29.
2
Rituximab after Autologous Stem-Cell Transplantation in Mantle-Cell Lymphoma.套细胞淋巴瘤自体干细胞移植后利妥昔单抗的应用。
N Engl J Med. 2017 Sep 28;377(13):1250-1260. doi: 10.1056/NEJMoa1701769.
3
Phase I First-in-Human Study of Venetoclax in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma.维奈托克在复发或难治性非霍奇金淋巴瘤患者中的I期首次人体研究。
J Clin Oncol. 2017 Mar 10;35(8):826-833. doi: 10.1200/JCO.2016.70.4320. Epub 2017 Jan 17.
4
Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.Ki-67 指数、细胞学和生长模式在套细胞淋巴瘤中的预后价值：来自欧洲套细胞淋巴瘤网络的随机试验结果。
J Clin Oncol. 2016 Apr 20;34(12):1386-94. doi: 10.1200/JCO.2015.63.8387. Epub 2016 Feb 29.
5
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase 3 study.依鲁替尼对比替西罗莫司治疗复发或难治性套细胞淋巴瘤患者：一项国际性、随机、开放标签、3 期研究。
Lancet. 2016 Feb 20;387(10020):770-8. doi: 10.1016/S0140-6736(15)00667-4. Epub 2015 Dec 7.
6
Lenalidomide plus Rituximab as Initial Treatment for Mantle-Cell Lymphoma.来那度胺联合利妥昔单抗作为套细胞淋巴瘤的初始治疗方案
N Engl J Med. 2015 Nov 5;373(19):1835-44. doi: 10.1056/NEJMoa1505237.
7
Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results.单药伊布替尼治疗套细胞淋巴瘤患者的长期随访：安全性和疗效结果更新
Blood. 2015 Aug 6;126(6):739-45. doi: 10.1182/blood-2015-03-635326. Epub 2015 Jun 9.
8
Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.硼替佐米为基础的治疗新诊断的套细胞淋巴瘤。
N Engl J Med. 2015 Mar 5;372(10):944-53. doi: 10.1056/NEJMoa1412096.
9
Allogeneic stem cell transplantation for mantle cell lymphoma--final report from the prospective trials of the East German Study Group Haematology/Oncology (OSHO).异基因造血干细胞移植治疗套细胞淋巴瘤——来自德国东部血液学/肿瘤学研究组前瞻性试验的最终报告(OSHO)。
Ann Hematol. 2014 Sep;93(9):1587-97. doi: 10.1007/s00277-014-2087-z. Epub 2014 Apr 30.
10
Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group.国际淋巴瘤放射肿瘤学组的结外非霍奇金淋巴瘤现代放射治疗——靶区定义和剂量指南。
Int J Radiat Oncol Biol Phys. 2014 May 1;89(1):49-58. doi: 10.1016/j.ijrobp.2014.01.006.
Zotero 插件